Related Experiment Video

Updated: Dec 10, 2025

Reducing State Anxiety Using Working Memory Maintenance
08:17

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

8.0K

Predictors of heart-focused anxiety in patients with stable heart failure

Sonja Maria Wedegärtner1, Igor Schwantke1, Ingrid Kindermann1

  • 1Department of Internal Medicine III (Cardiology, Angiology, and Intensive Care) of the Saarland University Medical Center, Saarland University; Kirrberger Str. 100, Building 24; 66421 Homburg/Saar, Germany.

Journal of Affective Disorders
|September 3, 2020
PubMed

Insights

Heart-focused anxiety in heart failure patients is predictable by psychological factors like self-reported anxiety and quality of life. Lifestyle and renal function (eGFR) also predict this anxiety, aiding early intervention.

Area of Science:

  • Cardiology and Psychology
  • Psychosomatic Medicine

Background:

  • Heart-focused anxiety is linked to adverse outcomes in heart disease patients.
  • Limited research exists on predictors of heart-focused anxiety in this population.

Purpose of the Study:

  • Identify predictors of heart-focused anxiety in stable heart failure patients.
  • Facilitate early identification of high-risk individuals for adverse outcomes.

Main Methods:

  • Assessed heart-focused anxiety in 107 stable chronic heart failure patients.
  • Evaluated psychological, demographic/lifestyle, and medical/laboratory variables.

Main Results:

  • Self-reported anxiety and quality of life were key predictors.
  • Conscientiousness, physical activity, and estimated glomerular filtration rate (eGFR) also showed predictive validity.

Conclusions:

  • Heart-focused anxiety is predictable by psychological and lifestyle variables.
  • eGFR is a significant laboratory predictor.
  • Identifying these predictors aids in detecting comorbid anxiety and directing psychological care.
Abstract

Keywords:
Cardiac anxiety questionnaireeGFRheart failureheart-focused anxietyphysical activityquality of life

More Related Videos

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

2.6K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

447

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
187
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
306
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
621
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Panic Disorder01:27

Panic Disorder

Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
407
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
743